Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.  Kesten JM, Holland A, Linton MJ, Family H, Scott J, Horwood J, Hickman M, Telfer M, Ayres R, Huss…

The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.  Alexander K, Pogorzelska-Maziarz M, Gerolamo A, Hassen N, Kelly EL, Rising KL.  Subst Abuse Treat Prev Policy. 2021 Aug 9;16(1):60. doi: 10.1186…

Treating Opioid Use Disorder in Puerto Rico During the COVID-19 Pandemic: Providers' Leadership Efforts in Unprecedented Times.  Quiñones DS, Melin K, Roman L, Rodriguez F, Alvarado J, Rodríguez-Díaz CE.  J Addict Med. 2021 Jul-Aug 01;15…

Patient-Centered Telehealth Solution for Observed Urine Collections in Substance Use Disorder Care Delivery During COVID-19 and Beyond.  Brett A, Foster H, Joseph M, Warrington JS.  J Patient Exp. 2021 Jul 29;8:23743735211033128. doi: 10…

Challenges in delivering telemedicine to vulnerable populations: experiences of an addiction medical service during COVID-19.  Hew A, Arunogiri S, Lubman DI.  Med J Aust. 2021 Aug 7. doi: 10.5694/mja2.51213. Epub ahead of print. PMID: 34…

An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.  Hughes PM, Verrastro G, Fusco CW, Wilson CG, Ostrach B.  J Rural Health. 2021 Jun;37(3):467-472. doi: 10.1…